Literature DB >> 34101979

Single-agent rituximab for treatment of multifocal and multiple relapsed pulmonary inflammatory myofibroblastic tumor in an adolescent patient.

Nicholas Farris1, Megan Sampson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34101979     DOI： 10.1002/pbc.29131

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  3 in total

Review 1.  Inflammatory Myofibroblastic Tumour: State of the Art.

Authors:  Louis Gros; Angelo Paolo Dei Tos; Robin L Jones; Antonia Digklia
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

2.  Treatment, pathological characteristics, and prognosis of pulmonary inflammatory myofibroblastic tumor-a retrospective study of 8 cases.

Authors:  Xiao Zhu; Wen-Bang Chen; Fu-Bao Xing; Shao Zhou; Zhen Tang; Xiao-Jun Li; Lei Zhang; Yu-Chen Huang
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

3.  Treatment of Pediatric Inflammatory Myofibroblastic Tumor: The Experience from China Children's Medical Center.

Authors:  Youhong Dong; Kashif Rafiq Zahid; Yidi Han; Pengchao Hu; Dongdong Zhang
Journal:  Children (Basel)       Date:  2022-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.